Challenges in managing hepatitis C virus infection in cancer patients

World Journal of Gastroenterology

Volumn 20, Issue 11, 2014, Pages 2771-2776

  Borchardt, Roy A ^a   Torres, Harrys A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Antiviral; Cancer; Chemotherapy; Hematopoietic stem cell transplant; Hepatitis C virus; Pegylated interferon; Ribavirin; Treatment

Indexed keywords

ALPHA2B INTERFERON PLUS RIBAVIRIN; BOCEPREVIR; TELAPREVIR; ANTIVIRUS AGENT;

ANEMIA; APPETITE DISORDER; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; DEPRESSION; DIAGNOSTIC VALUE; DIARRHEA; DISEASE ASSOCIATION; DYSPNEA; FATIGUE; FEVER; FLU LIKE SYNDROME; GENETIC VARIABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS C; HUMAN; INFECTION; INSOMNIA; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; MILD RENAL IMPAIRMENT; MORBIDITY; NAUSEA AND VOMITING; NEOPLASM; NEUTROPENIA; OVERALL SURVIVAL; PERSONALITY DISORDER; PREVALENCE; PRURITUS; RASH; RISK ASSESSMENT; THROMBOCYTOPENIA; COMPLICATION; GENETICS; HEPACIVIRUS; VIROLOGY;

ANTIVIRAL AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPACIVIRUS; HEPATITIS C; HUMANS; NEOPLASMS;

EID: 84896455490     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i11.2771     Document Type: Article

References (35)

1. Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61: 1-32 [PMID: 22895429]
2. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-1374 [PMID: 19330875 DOI: 10.1002/hep.22759]
3. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127: 1372-1380 [PMID: 15521006 DOI: 10.1053/j.gastro.2004.07.020]
4. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-1732 [PMID: 14724825 DOI: 10.1053/j.gastro.2003.09.025]
5. Fujii Y, Kaku K, Tanaka M, Yosizaki M, Kaneko T, Matumoto N. Hepatitis C virus infection in patients with leukemia. Am J Hematol 1994; 46: 278-282 [PMID: 8037177 DOI: 10.1002/ajh.2830460405]
6. Markovic S, Drozina G, Vovk M, Fidler-Jenko M. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepatogastroenterology 1999; 46: 2925-2930 [PMID: 10576374]
7. Faggioli P, De Paschale M, Tocci A, Luoni M, Fava S, De Paoli A, Tosi A, Cassi E. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma. Haematologica 1997; 82: 38-42 [PMID: 9107080]
8. Vento S, Cainelli F, Longhi MS. Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol 2002; 3: 333-340 [PMID: 12107020 DOI: 10.1016/S1470-2045(02)00773-8]
9. Torres HA, Boeckh M, Chemaly RF. Viral infections. In: Yeung SJ, Escalante C, Gagel RF, editors. Internal medicine care of cancer patient. 1st ed. Shelton, CT: BC Decker Inc., 2009: 151-161
10. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143-1238 [PMID: 19747629 DOI: 10.1016/j.bbmt.2009.06.019]
11. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Trop Gastroenterol 2007; 28: 19-23 [PMID: 17896605]
12. Locasciulli A, Cavalletto D, Pontisso P, Cavalletto L, Scovena E, Uderzo C, Masera G, Alberti A. Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 1993; 82: 2564-2567 [PMID: 7691264]
13. Torres HA, Davila M. Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer. Nat Rev Clin Oncol 2012; 9: 156-166 [PMID: 22271089 DOI: 10.1038/nrclinonc.2012.1]
14. Peffault de Latour R, Lévy V, Asselah T, Marcellin P, Scieux C, Adès L, Traineau R, Devergie A, Ribaud P, Espérou H, Gluckman E, Valla D, Socié G. Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 2004; 103: 1618-1624 [PMID: 14576071 DOI: 10.1182/blood-2003-06-2145]
15. Torres HA, Mahale P, Davila M, Mulanovich V, Granwehr B, Kontoyiannis DP, Raad II. Hepatitis C virus infection in cancer patients: the story of a forgotten population. In: Abstracts of the 48th Annual Meeting of the Infectious Diseases Society of America: 2010 Oct 21-24; Canada: Vancouver, 2010
16. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962-973 [PMID: 16149085 DOI: 10.1002/hep.20819]
17. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment Web resource. Hepatology 2014; 59: 318-327 [PMID: 24115039 DOI: 10.1002/hep.26744]
18. Nainan OV, Alter MJ, Kruszon-Moran D, Gao FX, Xia G, McQuillan G, Margolis HS. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology 2006; 131: 478-484 [PMID: 16890602 DOI: 10.1053/j.gastro.2006.06.007]
19. Torres HA, Nevah MI, Barnett BJ, Mahale P, Kontoyiannis DP, Hassan MM, Raad II. Hepatitis C virus genotype distribution varies by underlying disease status among patients in the same geographic region: a retrospective multicenter study. J Clin Virol 2012; 54: 218-222 [PMID: 22459004 DOI: 10.1016/j.jcv.2012.03.002]
20. Torres HA, Adachi JA, Roach LR, Smith KM, Mahale PS, Davila M, Raad II. Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way. Clin Infect Dis 2012; 54: 740-742 [PMID: 22322272 DOI: 10.1093/cid/cir930]
21. Pearlman BL, Traub N. Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more. Clin Infect Dis 2011; 52: 889-900 [PMID: 21427396 DOI: 10.1093/cid/cir076]
22. Mahale P, Okhuysen PC, Torres HA. Does Chemotherapy Cause Viral Relapse in Cancer Patients With Hepatitis C Infection Successfully Treated With Antivirals? Clin Gastroenterol Hepatol 2013; Epub ahead of print [PMID: 24211293]
23. Arcaini L, Merli M, Passamonti F, Bruno R, Brusamolino E, Sacchi P, Rattotti S, Orlandi E, Rumi E, Ferretti V, Rizzi S, Meli E, Pascutto C, Paulli M, Lazzarino M. Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. Am J Hematol 2010; 85: 46-50 [PMID: 19957347]
24. Morgan RL, Baack B, Smith BD, Yartel A, Pitasi M, Falck-Ytter Y. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med 2013; 158: 329-337 [PMID: 23460056 DOI: 10.7326/0003-4819-158-5-201303050-00005]
25. Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Khouri IF, Nieto YL, Champlin RE, de Lima M. Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica 2009; 94: 249-257 [PMID: 19144658 DOI: 10.3324/haematol.13756]
26. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 2012; 57: 1177-1185 [PMID: 22871500 DOI: 10.1016/j.jhep.2012.07.031]
27. Jou JH, Muir AJ. In the clinic. Hepatitis C. Ann Intern Med 2012; 157: ITC6-1-ITC6-16 [PMID: 23208180 DOI: 10.7326/0003-4819-157-11-20121204-01006]
28. Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006; 355: 2444-2451 [PMID: 17151366 DOI: 10.1056/NEJMct061675]
29. Mauss S, Hueppe D, Alshuth U. Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir. Hepatology 2014; 59: 46-48 [PMID: 23813604]
30. Perry CM. Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C. Drugs 2012; 72: 619-641 [PMID: 22439668 DOI: 10.2165/11208370-000000000-00000]
31. Torres HA, Mahale P, Saxena A, Afshar-Kharghan V, Kroll MH, Oo TH. Use of growth factors in treatment of hepatitis C viral infection in cancer patients. Annual Meeting of the American Society of Hematology in Atlanta. Blood: Georgia suppl, 2012: abstract 4725
32. Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer 2013; 21: 1525-1550 [PMID: 23314601 DOI: 10.1007/s00520-012-1688-0]
33. Sockalingam S, Links PS, Abbey SE. Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update. J Viral Hepat 2011; 18: 153-160 [PMID: 21070503 DOI: 10.1111/j.1365-2893.2010.01393.x]
34. Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry 2013; 13: 140 [PMID: 23679841 DOI: 10.1186/1471-244X-13-140]
35. Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 2013; 14: 721-732 [PMID: 23759376 DOI: 10.1016/S1470-2045(13)70244-4]